Streetbeat News

Stock Prices

FCX

Traders are closely watching Freeport-McMoRan (FCX) as its shares experience increased volume following a report that Investor Business Daily's SwingTrader has purchased the stock. This development has caught the attention of the market, indicating a potential shift in investor sentiment towards FCX.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 2:42 pm

FXI

TSLA

Xiaomi has received over 20,000 orders within the first 7 minutes of unveiling its electric vehicle (EV), indicating strong market interest.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 2:38 pm

UBXG

Trading for the IPO security UBXG was halted but has now resumed as of 10:35:00 AM ET.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 2:35 pm

BRZE

Braze shares are trading lower following the company's announcement of softer than expected earnings per share (EPS) guidance for the first quarter and the full fiscal year 2025.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 2:34 pm

SMTC

Semtech Corporation (NASDAQ:SMTC) is anticipated to report a Q4 loss of 3 cents per share, contrasting with a profit of 47 cents per share in the same quarter last year. Despite the expected loss, revenue is projected to increase to $196.46 million from $167.51 million year-over-year. Following better-than-expected Q3 earnings, Semtech's shares rose 10.7% to close at $27.86. Analysts from Baird, Susquehanna, Stifel, Needham, and Benchmark have recently updated their ratings and price targets for Semtech, with most maintaining positive outlooks.

Portfolio Pulse from Avi Kapoor

March 28, 2024 | 2:32 pm

AVTX

BDRX

GMDA

KOD

PMEC

XLO

U.S. stocks showed mixed performance with the Dow Jones slightly down, NASDAQ falling, and S&P 500 gaining. Avalo Therapeutics surged 435% after acquiring a Phase 2-ready anti-IL-1β mAb and announcing a significant private placement financing. Xilio Therapeutics soared 154% following an exclusive license agreement with Gilead Sciences. Biodexa Pharmaceuticals also saw a significant rise after promising results against brain cancers. Conversely, Primech Holdings, Gamida Cell, and Kodiak Sciences experienced notable declines. U.S. initial jobless claims dropped to 210,000, and the U.S. economy grew by 3.4% in Q4.

Portfolio Pulse from Avi Kapoor

March 28, 2024 | 2:32 pm

WNNR

ZPTA

Zapata AI and Andretti Acquisition Corp. (NYSE:WNNR) have completed their business combination, with Zapata AI's shares set to trade on Nasdaq under the ticker 'ZPTA'. This move provides Zapata AI with the financial flexibility to fuel innovation and drive enterprise customer acquisition, leveraging its proprietary industrial generative AI techniques. The company, now operating as Zapata AI, aims to solve complex industrial-scale problems for enterprises and government customers, including notable names like Sumitomo Mitsui Trust Bank and DARPA. Zapata AI's offerings, including Zapata AI Sense and Zapata AI Prose, are powered by its Orquestra reference architecture, supporting integration across multiple cloud environments.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 2:31 pm

KMI

Kinder Morgan's (NYSE:KMI) short interest has decreased by 9.2%, with 28.67 million shares sold short, representing 1.48% of its float. This decrease in short interest could indicate a more bullish sentiment towards KMI among traders. Compared to its peers, KMI has a lower short interest percentage of float, with the average being 3.67%. This information suggests that KMI is performing relatively well against its competitors in terms of market sentiment.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 2:30 pm

LLY

Eli Lilly and Co (NYSE:LLY) has significantly outperformed the market in the last 5 years, with an annualized return of 43.59%, turning a $1000 investment into $6,117.24. The company's market capitalization stands at $741.67 billion.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 2:30 pm

SCCO

Over the past 10 years, Southern Copper (NYSE:SCCO) has produced an average annual return of 13.45%, outperforming the market by 2.72% annually. With a current market capitalization of $81.68 billion, a $1000 investment in SCCO a decade ago would be worth $3,568.05 today. This showcases the significant impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 2:30 pm